Empagliflozin (Jardiance®)

Assessment Status Rapid review complete
Drug Empagliflozin
Brand Jardiance®
Indication Add-on combination therapy: In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control. Monotherapy: When diet and exercise alone do not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate due to intolerance.
Assessment Process
Rapid review commissioned 22/05/2014
Rapid review completed 12/06/2014
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended